Clarivate (NYSE:CLVT) Q3 2025 Earnings Call October 29, 2025 09:00 AM ET Company ParticipantsMatti Tov - CEOGreg Parrish - VP in Equity ResearchShlomo Rosenbaum - Managing DirectorMark Donohue - Head of Investor RelationsWill Qi - Equity Research Senior AssociateJonathan Collins - EVP and CFOConference Call ParticipantsGeorge Tong - Business Services Senior Research AnalystSurinder Thind - Equity Research AnalystScott Wurtzel - VP and Equity Research AnalystManav Patnaik - Research AnalystOperatorThank you ...

Clarivate (NYSE:CLVT) Q3 2025 Earnings Call October 29, 2025 09:00 AM ET Speaker5Thank you for standing by. At this time, I would like to welcome everyone to today's Clarivate Q3 2025 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you'd like to ask a question during this time, simply press star followed by the number one on your telephone keypad. Once again, star one. If you'd like to ...

Q3 2025 Earnings Call October 29, 2025 Safe Harbor Statement and Non-GAAP Financial Measures Forward-Looking Statements This communication includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements" within the meaning of the "safe harbor provisions" of the Private Securities Litigation Reform Act of 1995. These forward-looking statements c ...

Q2 2025 Earnings Call July 30, 2025 Safe Harbor Statement and Non-GAAP Financial Measures Forward-Looking Statements This communication includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions, or projections regarding future events or future results and therefore are, or may be deemed to be, "forward-looking statements" within the meaning of the "safe harbor provisions" of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can ...

Core Insights - Clarivate Plc has launched DRG Commercial Analytics 360, a solution aimed at enhancing commercial performance for medtech companies by providing advanced insights into customer activity and market dynamics [1][2]. Group 1: Product Features - DRG Commercial Analytics 360 integrates the Procedure Finder's search capabilities with Clarivate's extensive provider and affiliations network, delivering real-world, data-driven intelligence [2]. - The platform enables precise omnichannel targeting, seamless integration, and intelligent bundling, allowing medtech companies to make data-driven decisions that improve patient access and business outcomes [3]. - The solution offers actionable intelligence by providing tailored insights into healthcare providers, their network affiliations, and the locations where procedures are performed [5]. Group 2: Market Impact - The platform categorizes procedures by type and eliminates code-level duplication, ensuring a reliable view of procedure volume and flow across the U.S. market [5]. - It provides 360-degree market visibility through modularized claims and code groupings, supporting accurate market sizing and informed resource allocation [5]. - Clarivate's data scientists apply tailored extrapolation methodologies to derive nuanced insights across various market segments, backed by expertise in medtech and U.S. healthcare [5].